678 related articles for article (PubMed ID: 25719862)
21. Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target.
Wang F; Muller S
Front Immunol; 2015; 6():252. PubMed ID: 26042127
[TBL] [Abstract][Full Text] [Related]
22. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
Suh CH; Freed JH; Cohen PL
J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397
[TBL] [Abstract][Full Text] [Related]
23. Immunization with a bacterial ATP-binding cassette transporter fragment suppresses autoimmunity and prolongs survival in MRL/lpr lupus-prone mice.
Chang M; Walker SE; Hoffman RW
Lupus; 2000; 9(9):655-63. PubMed ID: 11199919
[TBL] [Abstract][Full Text] [Related]
24. Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus.
Monneaux F; Parietti V; Briand JP; Muller S
Arthritis Res Ther; 2007; 9(5):R111. PubMed ID: 17963484
[TBL] [Abstract][Full Text] [Related]
25. Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide.
Maueröder C; Schall N; Meyer F; Mahajan A; Garnier B; Hahn J; Kienhöfer D; Hoffmann MH; Muller S
Front Immunol; 2017; 8():16. PubMed ID: 28191006
[TBL] [Abstract][Full Text] [Related]
26. Molecular control of chaperone-mediated autophagy.
Catarino S; Pereira P; Girão H
Essays Biochem; 2017 Dec; 61(6):663-674. PubMed ID: 29233876
[TBL] [Abstract][Full Text] [Related]
27. Generation of self-peptides to treat systemic lupus erythematosus.
Briand JP; Schall N; Muller S
Methods Mol Biol; 2014; 1134():173-92. PubMed ID: 24497362
[TBL] [Abstract][Full Text] [Related]
28. Resetting the autoreactive immune system with a therapeutic peptide in lupus.
Schall N; Muller S
Lupus; 2015 Apr; 24(4-5):412-8. PubMed ID: 25801884
[TBL] [Abstract][Full Text] [Related]
29. [The spliceosome and its interest for lupus therapy].
Monneaux F; Muller S
Rev Med Interne; 2007 Oct; 28(10):725-8. PubMed ID: 17553599
[TBL] [Abstract][Full Text] [Related]
30. LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles.
Qiao L; Hu J; Qiu X; Wang C; Peng J; Zhang C; Zhang M; Lu H; Chen W
Autophagy; 2023 Nov; 19(11):2837-2852. PubMed ID: 37469132
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.
Zheng ZG; Zhu ST; Cheng HM; Zhang X; Cheng G; Thu PM; Wang SP; Li HJ; Ding M; Qiang L; Chen XW; Zhong Q; Li P; Xu X
Autophagy; 2021 Jul; 17(7):1592-1613. PubMed ID: 32432943
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.
Matsui C; Deng L; Minami N; Abe T; Koike K; Shoji I
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695419
[TBL] [Abstract][Full Text] [Related]
33. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules.
Anderson CC; Mukherjee R; Sinclair NR; Jevnikar AM
Clin Exp Immunol; 1997 Sep; 109(3):473-9. PubMed ID: 9328125
[TBL] [Abstract][Full Text] [Related]
34. LAMP-2C Inhibits MHC Class II Presentation of Cytoplasmic Antigens by Disrupting Chaperone-Mediated Autophagy.
Pérez L; McLetchie S; Gardiner GJ; Deffit SN; Zhou D; Blum JS
J Immunol; 2016 Mar; 196(6):2457-65. PubMed ID: 26856698
[TBL] [Abstract][Full Text] [Related]
35. Chaperone-Mediated Autophagy and Its Emerging Role in Hematological Malignancies.
Robert G; Jacquel A; Auberger P
Cells; 2019 Oct; 8(10):. PubMed ID: 31623164
[TBL] [Abstract][Full Text] [Related]
36. Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.
Cacciottolo M; Nogalska A; D'Agostino C; Engel WK; Askanas V
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):750-61. PubMed ID: 23452232
[TBL] [Abstract][Full Text] [Related]
37. ATG5 is required for B cell polarization and presentation of particulate antigens.
Arbogast F; Arnold J; Hammann P; Kuhn L; Chicher J; Murera D; Weishaar J; Muller S; Fauny JD; Gros F
Autophagy; 2019 Feb; 15(2):280-294. PubMed ID: 30196744
[TBL] [Abstract][Full Text] [Related]
38. Fluorescent-based evaluation of chaperone-mediated autophagy and microautophagy activities in cultured cells.
Sato M; Seki T; Konno A; Hirai H; Kurauchi Y; Hisatsune A; Katsuki H
Genes Cells; 2016 Aug; 21(8):861-73. PubMed ID: 27377049
[TBL] [Abstract][Full Text] [Related]
39. Chaperone-mediated autophagy in aging and disease.
Massey AC; Zhang C; Cuervo AM
Curr Top Dev Biol; 2006; 73():205-35. PubMed ID: 16782460
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of PLK3 Mediates the Degradation of Abnormal Prion Proteins Dependent on Chaperone-Mediated Autophagy.
Wang H; Tian C; Sun J; Chen LN; Lv Y; Yang XD; Xiao K; Wang J; Chen C; Shi Q; Shao QX; Dong XP
Mol Neurobiol; 2017 Aug; 54(6):4401-4413. PubMed ID: 27344333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
